# Maternal-Fetal Medicine Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charlotte Brontë (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI025-SYN-TD
- Date: 1855-01-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margaret Oyelaran-Hughes, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Eleanor Thwaite, MD

## Reason for consultation

First pregnancy at 38, at 7 weeks 1 day by today's dating scan, with moderate nausea and vomiting for a week and early weight loss. Please advise on the plan if it worsens, on aneuploidy screening and diagnostic options at her age, on preeclampsia prevention, and on her tuberculosis risk. **S**

## History

Ms. Brontë is seen at the request of Dr. Thwaite at 8 weeks 1 day. Nausea has worsened over the week despite doxylamine-pyridoxine two tablets at bedtime: she vomits four or five times a day, keeps down small amounts of fluid and dry food most days, and feels lightheaded only on standing quickly. PUQE-24 score 11. She has had no pain, bleeding, fever, or diarrhea, and no palpitations or tremor. This is a planned first pregnancy; she has no previous pregnancies, no chronic illness, and no thyroid disease. Her elder sisters died of tuberculosis in childhood and two other sisters as young adults, in her household; she has no cough, night sweats, or fever. She is anxious about carrying a pregnancy at her age after losing her mother and sisters young, and wants clear information. **S**

## Examination

| System | Finding |
|---|---|
| General | Slight and tired; not distressed |
| Hydration | Mucous membranes slightly dry; no orthostatic drop; pulse 92; blood pressure 102/64 mmHg |
| Neck | Thyroid not enlarged |
| Abdomen | Soft and non-tender |

BP 102/64 mmHg; pulse 92 bpm; respirations 14/min; temperature 36.8 °C; oxygen saturation 99% on room air; weight 44 kg; BMI 19 kg/m². All vital signs are synthetic.

## Data reviewed

Today's weight (44.0 kg, 4.3 percent below her pre-pregnancy weight), vital signs, and metabolic panel (normal, potassium 3.6 mmol/L); the dating scan; the first prenatal tests (blood group O RhD positive, antibody screen negative, rubella immune, hepatitis B, HIV, syphilis, and hepatitis C negative, urine culture no growth); the interferon-gamma release assay (negative); PHQ-9 5. Sodium: 136 mmol/L; Potassium: 3.6 mmol/L; Chloride: 99 mmol/L; Bicarbonate (total CO2): 26 mmol/L; BUN: 11 mg/dL; Creatinine: 0.58 mg/dL; Glucose: 74 mg/dL; Urine ketones: 40 mg/dL (high). All results are synthetic.

## Assessment

1. **Nausea and vomiting of pregnancy, moderate and worsening** (O21.9). PUQE-24 score 11 with 4.3 percent weight loss and normal electrolytes; not yet hyperemesis gravidarum, but at risk of it. Severity is judged by the PUQE-24 score, weight, hydration, and electrolytes; urine ketones are not a measure of dehydration. **S**
2. **First pregnancy at 38** (O09.519). A singleton pregnancy at an advanced maternal age with no other risk factor yet identified. Two moderate preeclampsia risk factors (nulliparity and age 35 or older). The negative interferon-gamma release assay, with no symptoms, excludes latent tuberculosis infection for practical purposes; old household exposure needs no further testing. **S**

## Recommendations

1. Raise doxylamine-pyridoxine to four tablets a day now and add metoclopramide 10 mg three times a day before meals, stopping it at once if restlessness or abnormal movements occur.
2. Ondansetron is a reasonable next step even before 10 weeks if these fail: counsel her that the absolute increase in orofacial clefting is very small and must be weighed against uncontrolled vomiting; check potassium, magnesium, and the QTc first if electrolytes are abnormal.
3. Same-day assessment, with admission or day-unit care, if she cannot keep fluids down for 24 hours, loses more than 5 percent of her pre-pregnancy weight, is orthostatic, or has electrolyte abnormalities. Then give 0.9% saline with potassium guided by daily electrolytes, thiamine before any dextrose, magnesium and phosphate replacement with refeeding precautions, and weight-adjusted low-molecular-weight heparin while admitted; check TSH, free T4, and liver tests, expecting a suppressed TSH from hCG that needs no antithyroid drug.
4. Offer cell-free DNA screening from 10 weeks with a nuchal translucency scan at 11 to 14 weeks, or diagnostic testing by chorionic villus sampling from 10 weeks or amniocentesis from 15 weeks; she prefers screening, with diagnostic testing only after a positive screen.
5. Start aspirin 81 mg at bedtime between 12 and 16 weeks and continue to delivery.
6. No further tuberculosis testing is needed; a chest radiograph with shielding only if symptoms develop.
7. Detailed anatomy scan at 18 to 22 weeks; mood screening each trimester and after any admission; standard glucose screening at 24 to 28 weeks; in the third trimester, a growth scan and a discussion of antenatal fetal surveillance and the timing of delivery.

## Strengths and supports

- Supports: her husband, a close friend from school days with whom she writes often, and the household's long-serving help **S**

## Communication

Discussed with Dr. Thwaite the same day; Ms. Brontë agrees with the plan. **S**

## Follow-up

Primary obstetric care continues with Dr. Thwaite. Maternal-fetal medicine will see her again for the anatomy scan, sooner if a screen is positive or hyperemesis needs admission. **S**

## Guideline basis

- ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024), Royal College of Obstetricians and Gynaecologists (BJOG)
- Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (Green-top Guideline No. 37a) (2015), Royal College of Obstetricians and Gynaecologists
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force
- Latent Tuberculosis Infection in Adults: Screening (2023), U.S. Preventive Services Task Force
- 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (2017), American Thyroid Association (Thyroid)
